Assessment of Variability in the SOMAscan Assay
暂无分享,去创建一个
Yuri Kotliarov | Julián Candia | Foo Cheung | Angélique Biancotto | John S. Tsang | Giovanna Fantoni | Brian Sellers | Trevor Griesman | Jinghe Huang | Sarah Stuccio | Adriana Zingone | Bríd M. Ryan | J. Tsang | G. Fantoni | A. Zingone | Jinghe Huang | B. Ryan | A. Biancotto | Foo Cheung | Trevor Griesman | J. Candia | Yuri Kotliarov | B. Sellers | Sarah Stuccio
[1] M. Croft. The role of TNF superfamily members in T-cell function and diseases , 2009, Nature Reviews Immunology.
[2] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.
[3] K. Davies,et al. Identification of serum protein biomarkers for utrophin based DMD therapy , 2017, Scientific Reports.
[4] Yuri Kotliarov,et al. Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses , 2014, Cell.
[5] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[6] Sheri K. Wilcox,et al. Protein Signature of Lung Cancer Tissues , 2012, PloS one.
[7] Magda Tsolaki,et al. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. , 2013, Journal of Alzheimer's disease : JAD.
[8] Mark R Segal,et al. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease. , 2016, JAMA.
[9] Hugues Bersini,et al. Batch effect removal methods for microarray gene expression data integration: a survey , 2013, Briefings Bioinform..
[10] Alternative ways of estimating serological titer reproducibility , 1981, Journal of clinical microbiology.
[11] Stephen A. Williams,et al. Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer , 2010, PloS one.
[12] Yudi Pawitan,et al. Multidimensional Normalization to Minimize Plate Effects of Suspension Bead Array Data. , 2016, Journal of proteome research.
[13] Larry Gold,et al. Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.
[14] M. Ruhwald,et al. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection , 2015, Scientific Reports.
[15] Xu Shi,et al. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease , 2016, Circulation.
[16] Richard T. Lee,et al. Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.
[17] George F. Reed,et al. Use of Coefficient of Variation in Assessing Variability of Quantitative Assays , 2002, Clinical and Vaccine Immunology.
[18] Christian Gieger,et al. Connecting genetic risk to disease end points through the human blood plasma proteome , 2016, Nature Communications.
[19] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[20] Fredrik Levander,et al. Normalyzer: A Tool for Rapid Evaluation of Normalization Methods for Omics Data Sets , 2014, Journal of proteome research.
[21] R. J. Wood,et al. Reproducibility of serological titers , 1980, Journal of clinical microbiology.
[22] Joel Dudley,et al. High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors , 2017, PLoS genetics.
[23] M. Sabatine. Using Aptamer-Based Technology to Probe the Plasma Proteome for Cardiovascular Disease Prediction. , 2016, JAMA.
[24] Stephen A. Williams,et al. Validation of a blood protein signature for non-small cell lung cancer , 2014, Clinical Proteomics.
[25] Jean-Pierre A. Kocher,et al. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis , 2013, Bioinform..
[26] Virginia Pascual,et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.
[27] Magda Tsolaki,et al. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology , 2014, Alzheimer's & Dementia.
[28] Chunyu Liu,et al. Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.
[29] Tracy R. Keeney,et al. Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.
[30] Yuri Kotliarov,et al. Web Tool for Navigating and Plotting SomaLogic ADAT Files , 2017, Journal of open research software.